MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER (mannitol) by B. Braun is osmotic activity [moa]. First approved in 1965.
Drug data last refreshed 4d ago
Mannitol 10% with Dextrose 5% is an osmotic diuretic injectable solution used for bowel preparation prior to diagnostic or surgical procedures. It works by creating an osmotic gradient that draws fluid into the bowel lumen, promoting evacuation. This product combines mannitol's osmotic activity with dextrose to provide both osmotic and nutritive support.
This product faces LOE risk with moderate competitive pressure (30%), signaling potential team consolidation and shift toward legacy product management or portfolio rationalization.
Osmotic Activity
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Inhaled Mannitol on Mucociliary Clearance in Moderate to Severe Cystic Fibrosis
PT027 Compared to PT007 in Patients With Asthma With Mannitol-induced Acute Airway Obstruction
Mannitol-Induced Cough Challenge in Healthy Controls and Subjects With Mild Allergic Asthma
A Study Comparing Picoprep With Mannitol and Bisacodyl for Colon Cleansing in Preparation for Colonoscopy
A Safety and Efficacy Trial of Inhaled Mannitol in Adult Cystic Fibrosis Subjects
Worked on MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER at B. Braun? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moThis product offers limited career growth opportunity as a legacy, LOE-approaching injectable with minimal linked job postings and stable-to-declining commercial trajectory. Career value lies in operational management, portfolio rationalization experience, and potential roles focused on cost containment and market maintenance rather than expansion.